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Abstract
Background: The acid-ash hypothesis, the alkaline diet, and related products are marketed to the general public. 
Websites, lay literature, and direct mail marketing encourage people to measure their urine pH to assess their health 
status and their risk of osteoporosis.
The objectives of this study were to determine whether 1) low urine pH, or 2) acid excretion in urine [sulfate + chloride 
+ 1.8x phosphate + organic acids] minus [sodium + potassium + 2x calcium + 2x magnesium mEq] in fasting morning 
urine predict: a) fragility fractures; and b) five-year change of bone mineral density (BMD) in adults.
Methods: Design: Cohort study: the prospective population-based Canadian Multicentre Osteoporosis Study. Multiple 
logistic regression was used to examine associations between acid excretion (urine pH and urine acid excretion) in 
fasting morning with the incidence of fractures (6804 person years). Multiple linear regression was used to examine 
associations between acid excretion with changes in BMD over 5-years at three sites: lumbar spine, femoral neck, and 
total hip (n = 651). Potential confounders controlled included: age, gender, family history of osteoporosis, physical 
activity, smoking, calcium intake, vitamin D status, estrogen status, medications, renal function, urine creatinine, body 
mass index, and change of body mass index.
Results: There were no associations between either urine pH or acid excretion and either the incidence of fractures or 
change of BMD after adjustment for confounders.
Conclusion: Urine pH and urine acid excretion do not predict osteoporosis risk.
Background
Osteoporosis is a disease that causes pain, disability,
reduced quality of life [1], mortality [2], and places sub-
stantial demands on health care budgets [3,4]. According
to the acid-ash hypothesis, the modern diet produces
residual acid after metabolism [5-7]. This diet-derived
acid is thought to be buffered by bicarbonate from bone,
followed by bone calcium excretion in the urine [5-7].
Numerous papers in the medical literature (experimen-
tal trials [6-14], cross sectional studies [5,15], prospective
studies [16-19], and animal models [20]) identify the
potential acid load of the diet as a risk factor for osteopo-
rosis. Well-respected textbooks [21] and reference works
[22,23] uphold this concept. Of public health importance,
the acid-ash hypothesis is marketed to the general public
as the "alkaline diet", to decrease acidity, to help the body
regulate its pH, and to prevent numerous disease pro-
cesses. Websites[24,25], lay literature [26-28], magazine
advertisements, and direct mail marketing encourage
people to measure their urine pH to assess their risk of
osteoporosis as well as their general health status [24,29].
Urine pH of people consuming modern diets tends to be
slightly acidic, with pH of approximately 6 [14,30]. When
urine pH is found to be acidic, the "alkaline diet" and the
purchase of products to achieve acid-base balance are
advocated.
In the medical literature, the diet acid load has been
quantified in food ([sulfate + chloride + 1.8x phosphate +
organic acids] minus [sodium + potassium + 2x calcium +
2x magnesium] in mEq/day [10]), as well as in urine
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[10,11,31]. The urine acid load has been quantified in two
ways: through the measurement of urine pH [10,11,31],
and from the measurement of net acid excretion [10,31-
33]. Traditionally the urine acid excretion has been esti-
mated from measured titratable acidity, ammonium and
bicarbonate [10,32], which may be inferior measures of
acid excretion since ammonium and bicarbonate are vol-
atile and altered by bacterial growth [34] and the mea-
surement of titratable acidity is not a precise method [35].
Urine measures of food intake or the diet acid load take
place after absorption has occurred, are not prone to food
intake reporting bias, and therefore may provide more
accurate estimates.
To our knowledge, the utility of urine pH and/or urine
measures of acid excretion to predict osteoporotic out-
comes has not been assessed. If urine pH and urine mea-
sures of the potential acid load of the diet can predict
which individuals are vulnerable to the development of
osteoporosis, a novel laboratory testing strategy could be
implemented to identify individuals at risk of accelerated
bone loss. However, if these measures do not predict
which individuals are vulnerable to osteoporosis, the
practice of urine pH testing to identify who is at risk for
this disease should be discouraged.
The objectives of this study were to determine whether
1) low urine pH, or 2) the calculated acid excretion in
urine predict: a) fragility fractures; and b) five-year
change of bone mineral density (BMD) in adults.
Methods
This study was approved by the Conjoint Health
Research Ethics Board, University of Calgary and the
Canadian Multicentre Osteoporosis Study (CaMOS)
Design, Analysis and Publication Committee. Informed
consent was obtained from the study participants at base-
line. CaMOS is a prospective population-based cohort
study designed to study skeletal health among a random
sample of Canadian adults 25 years of age and above
[36].The participants in this study included those
recruited from Quebec because they had urine and blood
samples obtained at both baseline and at 5-years (Figure
1). At baseline (1996-8) and at five years participants had
in-person interviews, measurement of BMD, and collec-
tion of samples. Fasting urine samples were collected in
the morning after an initial void and a wait of two hours,
while participants maintained a fast from the evening
before. The urine samples were aliquoted, frozen and
stored at -70°C in plastic vials within two hours of collec-
tion.
The outcome variables for this study were change of
BMD (Dual Energy X-ray Absorptiometry (Hologic
2000)) over 5-years (at the femoral neck (FN), the lumbar
spine (L1-4) (LS), and the total hip (HIP)) as well as fragil-
ity fractures over seven years of follow-up. Fractures, ini-
tially self-reported, were confirmed using radiology
reports, over seven years of follow-up. A fragility fracture
occurred spontaneously, after a no-fall injury, or from a
fall from a standing height or less.
The exposure variables used in this study were: urine
pH, and the concentration of the urine ions (mmol/l)
summed as estimated acid excretion ([sulfate + chloride +
1.8x phosphate + estimated organic acids [37]] - [potas-
sium + sodium + 2x calcium + 2xmagnesium] mEq/L)
[10] based on measurements made on in fasting morning
urine. Urine creatinine was included in the adjusted mod-
els to control for urine concentration. The urinary excre-
tion of organic acids (including citric, oxalic, malic,
succinic, lactic, glutamic, aspartic acid, etc) were esti-
mated from body surface area ([(body surface area × 41)/
1.73] [37], where 41 is the median daily organic acid
anion excretion (mEq/d) (body surface area was used by
these authors as [0.007184x height  (cm)0.725  ×  weight
(kg)0.425] [37] based on a recent study that found that
anthropometric measures predicted urine organic acids
(R2 of 0.15 to 0.39) better than diet measures [37].
Variables considered to be potential confounders
included: age, gender, reported family history of osteopo-
rosis among first degree relatives, body mass index
(BMI), change in BMI [38-40], hormonal status among
the women, presence or absence of kidney disease [41],
smoking, medications (thiazide diuretics, bisphospho-
nates, and estrogen) use, physical activity [42], calcium
intake, and vitamin D status. Vitamin D status was
assigned as adequate if the serum 25-hydroxy vitamin D
Figure 1 Flow diagram of the entry of subjects into the fracture 
and BMD studies.
Fracture study: Subjects contributed urine sample and had 
follow- up fracture data collected (n= 795)
No baseline collection of urine:
(n= 338)
No baseline and 5-year BMD completed
(n= 144)
1133 entered into Quebec City CaMOS cohort
Baseline questionnaires completed
BMD Study:
Baseline and 5 year BMD completed:  (n= 651)
Eligible for participation in 
Quebec City sub-cohort
(n= 1821)
Refused to 
participate, but 
completed refusal 
questionnaire
(n= 539, 29.6%)
Refused to participate 
at all
(n=145, 8.2%)Fenton et al. BMC Musculoskeletal Disorders 2010, 11:88
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was >= 80 nmol/l [43] (Table 1). Medication use was
based on prescription bottles viewed at baseline. Women
were coded at baseline as estrogen sufficient if they were
either premenopausal, or taking estrogen. Urine creati-
nine was included in the adjusted models to control for
urine concentration. Baseline BMD was included in the
adjusted models to control for the potential influence of
baseline BMD on the change over time [44].
Immediately after thawing, urine pH was measured
using a Radiometer PHM82 Standard pH Meter (Copen-
hagen, Denmark). The calcium, phosphate and creatinine
measurements were made using a Vitros 950 (Vitros
Chemistry product, Ortho-Clinical Diagnostics, Johnson
and Johnson Company, Rochester, NY, USA. Sodium,
potassium, magnesium, and chloride were measured
using Cobas Integra 700 analyzer (Roche Diagnostics,
F.Hoffmann-La Roche Ltd, Basel, Switzerland). Urine sul-
fate was measured using an automated methylthymol
blue method.
Regression analysis methods
Multiple logistic regression analysis was used for the frac-
tures analysis and linear regression analysis was used for
the BMD analysis. To determine the independent influ-
ence of urine pH, models were fully adjusted for potential
confounders. Missing values were frequent for smoking
status (44.9%), osteoporosis family history (26.8%) and
serum 25(OH) vitamin D (49%). Rather than excluding
subjects because they had missing values, a third category
was added to each of these variables to assess the effect of
missingness on outcome. As a result, two indicator vari-
ables were created to represent the 3 categories in the
regression analyses for each of these variables. Subse-
quent to performing logistic regression analyses, the pre-
dictive accuracies of urine pH and urine acid excretion
for fractures was quantified by the c-statistic, having val-
ues range from 0.5 (chance accuracy) to 1.0 (perfect accu-
racy), with the following intermediate benchmarks: 0.6
(fair), 0.7 (good), 0.8 (excellent), and 0.9 (almost perfect).
Stata, Version 10.1 (StataCorp, College Station, Texas,
USA), was used for the data analysis.
Results
The baseline questionnaire was completed by 1133 sub-
jects (Figure 1); 795 contributed baseline urine samples,
651 (81.9%) had two BMD measurements. The distribu-
tion of urine pH is shown in Figure 2. By year seven com-
plete fracture data was recorded for 6804 person years
among the 795 subjects. The baseline characteristics and
subjects' urine composition in the Fracture and BMD
studies were similar (Table 1 &2).
During follow-up, the mean FN BMD decreased signif-
icantly over 5-years by -0.68% (p < 0.001); the HIP BMD
did not change significantly (-0.11%) (p = 0.66); and the
LS increased significantly (1.92%) (p < 0.001) (Table 3).
Eighty-seven (10.9%) cohort subjects had 112 fractures;
46 (5.8%) subjects sustained confirmed fragility fractures.
Of those who sustained confirmed fragility fractures, 41
(89%) were aged 50 or greater.
Table 1: Baseline subject characteristics in the fracture and the BMD studies
Subject characteristics Fracture study BMD study
n 795 651
Age 59.8 +/- 12.8 58.6 +/- 12.3
Female gender, (%) 553/795 (69.6%) 455/651 (69.9%)
Women estrogen sufficient, (%) 261/553 (47.2%) 228/455 (50.1%)
Body Mass Index, kg/m2 26.1 +/- 4.7 26.0 +/- 4.7
Change of BMI, kg/m2 0.56 +/- 1.71 0.59 +/- 1.69
Physical activity, kcal/day 1548 +/- 589 1576 +/- 806
Family history of osteoporosis, (%) 71/511 (13.9%) 60/415 (14.5%)
Calcium intake, mg/day 889 +/- 550 885 +/- 551
Serum 25(OH) Vitamin D, nmol/l 75.1 +/- 28.4 74.9 +/- 28.4
Smoking, (%) 154/438 (35.2%) 113/352 (32.1%)
Caucasian race, (%) 792 (99.6%) 647 (99.4%)
Kidney Disease, (%) 119/733 (16.2%) 118/632 (18.7%)
Thiazide medications, (%) 66/795 (8.3%) 52/651 (8.0%)
Bisphosphonates, (%) 8/795 (1.0%) 6/651 (0.9%)
*mean +/- sd, nmol/l = nanomole per litreFenton et al. BMC Musculoskeletal Disorders 2010, 11:88
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Regression analysis results
There was no association between urine pH or urine acid
excretion and the occurrence of fragility fractures (Table
4). Subjects had similar risks of fracture for those with
low and high urine pH, whether or not potential con-
founders were controlled, since the odds ratios were all
close to one. The c-statistics illustrated that the unad-
justed models for both urine pH and urine acid excretion
did not discriminate any better than chance, while the
adjusted models had a good ability to predict who would
have a fracture (Table 4).
There were two statistically significant associations
among the unadjusted relationships between urine mea-
sures of acid excretion and change of BMD (Table 5):
urine acid excretion with both the change of BMD at the
FN and the LS (p = 0.026 and p = 0.041, respectively).
Both the slope coefficients and adjusted R2 were close to
zero, indicating poor associations. Once adjusted for
potential confounding variables, there was no relation-
ship between urine pH or urine acid excretion with the
five-year change of BMD for any of the three sites
assessed, FN, LS, or HIP (Table 5). Specifically, in the
unadjusted models, two relationships were statistically
significant: urine acid excretion with both the change of
BMD at the FN and the LS (p = 0.026 and p = 0.041,
respectively). However, no relationships were statistically
significant once confounding was controlled. Once
adjusted for confounding, individuals' BMD equally
increased and decreased for those with high and low
urine pH, and for those with high and low acid excretion.
The greatest amount of explained variance (adjusted R2)
for the adjusted models for each bone site ranged from
two to ten percent. Post estimation residual analysis did
not identify any concerns with the assumptions of linear
regression.
Discussion
This study revealed no significant associations between
either of the urine measures of dietary acid load, urine pH
or calculated acid excretion in urine [10], with the occur-
rence of fragility fractures over 7-years or changes in
BMD over 5-years at any of three sites (lumbar spine,
femoral neck, or total hip). The adjusted models are more
likely to be accurate estimations of the associations
between dietary acid load in fasting morning urine sam-
p l e s  a n d  b o n e  o u t c o m e s  t h a n  t h e  u n a d j u s t e d  m o d e l s
since the adjusted models control for other risk factors
and confounding [45].
The evidence to support the acid-ash hypothesis of
osteoporosis predominantly comes from studies using
changes in urine calcium as the outcome [6,8-12,46],
some prospective observational studies [16,18,19,47] and
one randomized trial [13]. Although one randomized
Figure 2 Distribution of urine pH.
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Table 2: Urine values at baseline
Urine values Fracture study BMD study
Urine pH 6.1 +/- 0.70 6.1 +/- 0.71
Calcium/creatinine, mmol/mmol 0.37 +/- 0.24 0.38 +/- 0.24
Chloride/creatinine, mmol/mmol 17.4 +/- 9.0 17.1 +/- 8.7
Magnesium/creatinine, mmol/mmol 0.43 +/- 0.20 0.43 +/- 0.20
Phosphate/creatinine, mmol/mmol 2.51 +/-0.84 2.53 +/-0.84
Potassium/creatinine, mmol/mmol 6.18 +/- 3.05 6.14 +/- 3.07
Sodium/creatinine, mmol/mmol 16.4 +/- 9.2 16.1 +/- 8.9
Sulfate/creatinine, mmol/mmol 2.09 +/- 0.85 2.08 +/- 0.85
Organic acids/creatinine, mmol/mmol 6.89 +/- 5.37 6.76 +/- 5.25
Urine creatinine, mmol/L 8.8 +/- 5.2 8.9 +/- 5.3
Acid excretion, mEq/L 46.6 +/- 25.0 47.5 +/- 25.4
*mean +/- sd, mmol = millimole, L = litre, mEq/L = milliequivalent/litreFenton et al. BMC Musculoskeletal Disorders 2010, 11:88
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trial has supported the hypothesis [13], another did not
[40]. The randomized trial [13] supporting the hypothesis
did not use concealment of allocation, a study quality
indicator for randomized studies that is important to
avoid bias during the randomization process [48]. With-
out concealment of allocation, investigators can influence
the allocation of individuals into the treatment groups,
invalidating the randomization. Trials that do not have
concealed allocation can overestimate effectiveness of a
therapy [49]. The more recent randomized trial, that con-
cealed allocation, did not reveal any protective effect of
either potassium citrate or increased fruit and vegetable
consumption on change in BMD [14].
Three previous prospective cohort studies of the
hypothesis reported some protective associations
between fruit and vegetable, potassium, and/or vitamin C
intakes and bone health [16,18,19], and thus may support
the hypothesis, while two more recent cohort studies do
not support it [50,51]. One of the positive reporting stud-
ies did not see a significant protective association for
potassium once potential confounders were controlled
[16]. Further, it is possible that the associations in agree-
ment with the hypothesis in the cohort studies were due
to uncontrolled confounding by estrogen status [19],
baseline BMD [16,19], change of weight status during fol-
low-up [18], and/or vitamin D status [16,18,19,47].
Further, three recent meta-analyses of the acid-ash
hypothesis do not support the hypothesis. First, a meta-
analysis of calcium balance studies, restricted to studies
of superior methodology, revealed no association
between net acid excretion and calcium balance, in spite
of the strong relationship between net acid excretion and
urinary calcium [52]. A systematic review and meta-anal-
ysis of the effect of protein intake on bone health revealed
a small beneficial effect of protein supplementation on
lumbar spine BMD in randomized placebo-controlled
Table 3: Bone outcomes in the Fracture and BMD studies
Fracture study BMD study
Bone Mineral Density (BMD):
Baseline FN BMD, g/cm2 0.727 +/- 0.128 0.731 +/- 0.126
Baseline LS BMD, g/cm2 0.936 +/- 0.166 0.938 +/- 0.160
Baseline HIP BMD, g/cm2 0.880 +/- 0.151 0.885 +/- 0.146
Change BMD, over 5-years
5-year change FN BMD, g/cm2 n/a -0.005 +/- 0.035
5-year change LS BMD, g/cm2 n/a 0.018 +/- 0.054
5-year change HIP BMD, g/cm2 n/a -0.001 +/- 0.036
Change FN BMD, % of baseline n/a -0.68% +/- 5.0
Change LS BMD, % of baseline n/a 1.9% +/- 6.0
Change HIP BMD, % of baseline n/a -0.11% +/- 4.2
Confirmed fragility fractures 46/795 (5.8%) n/a
*mean +/- sd, dichotomous variables are reported with (percentage), g/cm2 = gram per squared centimetres
Table 4: Multiple logistic regression analysis results: Urine pH and acid excretion associations with fragility fractures*
Fracture type Unadjusted estimate p-value Adjusted estimate p-value
Urine pH:
Fragility fractures Odds ratio: 1.07 0.76 0.97 0.91
95% confidence interval: 0.70 to 1.63 0.58 to 1.63
c-statistic: 0.514 0.731
Urine Acid excretion:
Fragility fractures Odds ratio: 1.00 0.76 1.00 0.92
95% confidence interval: 0.99 to 1.01 0.99 to 1.02
c-statistic: 0.510 0.731
*The following variables were included in the adjusted models to control for confounding: age, gender, family history of osteoporosis, body 
mass index (BMI), change in BMI, estrogen status, physical activity, calcium intake, vitamin D status, smoking, kidney disease, urine creatinine, 
thiazide diuretics, and bisphosphonate use.Fenton et al. BMC Musculoskeletal Disorders 2010, 11:88
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trials [53]. Further, the acid-ash hypothesis predicts
higher phosphate intakes would be associated with
increased urinary calcium and lower calcium balance, but
this was not supported by a third recent meta-analysis
[54].
We used urine samples that had been stored since base-
line. Urine pH may change slightly with storage as carbon
dioxide (CO2) and ammonia (NH3) evaporate, but the
changes are not likely to result in misrepresentation of
the measurements. As urine bicarbonate evaporates as
CO2 from alkaline urine (H+ and HCO3
- <--> H2O + CO2),
pH would increase through the loss of the hydrogen ions
[55]. As urine ammonia (NH3) evaporates from more
acidic urine, ammonium would converted to ammonia
(NH4
+ <--> H+ + NH3), hydrogen ions would be liberated
and therefore the measured hydrogen ion will increase
and thus the pH will decrease. Bicarbonate is found in
appreciable amounts only in more alkaline urine, and
ammonium in more acidic urine [56]. Therefore these
reactions, which cause the alkaline urine to become
somewhat more alkaline, and acidic urine to become
more acidic, would not likely cause misrepresentation of
the measurements of the potential risks.
Our study had four strengths. First, the population
from which the cohort was selected has wide ranges of
intakes for protein, potassium, fruit and vegetables
[57,58]. Therefore the sample likely had a range of expo-
sures, which improve the chances of revealing the rela-
tionship under investigation. Second, the outcome
measures used in this study, change in BMD (an accepted
clinical measure of the progression of this disease [59])
and occurrence of fragility fractures (a direct measure of
osteoporosis [60,61]) are superior measures of osteopo-
rosis relative to the measurement of urine calcium
changes. Third, the use of urine to measure the diet acid
load allowed us to avoid the random and systematic
errors inherent in food intake measurement. Food-based
calculations of acid load excretion are not very precise
[31], determining food intake is prone to reporting bias
[62,63], and the absorption of individual ions from food is
variable [10,64]. Food is a complex mixture of numerous
compounds, and nutrient absorption depends on the
chemical composition as well as "on various interactions
with many endogenous and exogenous factors" [35].
This study also had limitations. First, the exposures for
this study were measured in fasting morning urine sam-
ples, which might be inferior to measures made in 24-
hour urine samples. It is possible that urine pH or mea-
sures of acid excretion in 24-hour urine samples have a
relationship with bone outcomes, and it is also possible
that fasting-morning-second-void urines are more reli-
able measures of diet-acid than 24-hour collections that
are more prone to incomplete collection [65]. However,
proponents of the acid-ash hypothesis advocate the mea-
Table 5: Multiple linear regression analysis results: Urine pH and acid excretion associations with change of BMD*
Bone Site: Unadjusted estimate p-value Adjusted estimate p-value
Urine pH:
Femoral Neck Coefficient:
95% confidence interval:
aR2 :
0.0034
-0.0004 to 0.0073
0.003
0.08 0.0018
-0.0025 to 0.0062
0.086
0.41
Total hip Coefficient:
95% confidence interval:
aR2 :
0.0012
-0.0027 to 0.0051
0.001
0.54 0.0020
-0.0020 to 0.0066
0.096
0.29
Lumbar Spine Coefficient:
95% confidence interval:
aR2 :
0.0053
-0.0052 to 0.0111
0.003
0.07 0.0022
-0.0044 to 0.0089
0.026
0.51
Urine Acid excretion:
Femoral Neck Coefficient:
95% confidence interval:
aR2 :
-0.0001
-0.0002 to -0.00002
0.0062
0.026 -0.0001
-0.0002 to 0.00001
0.088
0.19
Total hip Coefficient:
95% confidence interval:
aR2 :
-0.0001
-0.0002 to 0.00005
0.001
0.26 -0.0001
-0.0002 to 0.0001
0.099
0.46
Lumbar Spine Coefficient:
95% confidence interval:
aR2 :
-0.0002
-0.0003 to -0.00001
0.005
0.041 -0.00002
-0.0002 to 0.0002
0.026
0.84
*The following variables were included in the adjusted models to control for confounding: age, gender, family history of osteoporosis, body mass 
index (BMI), change in BMI, estrogen status, physical activity, calcium intake, vitamin D status, smoking, kidney disease, urine creatinine, thiazide 
diuretics, bisphosphonate use and baseline BMD.Fenton et al. BMC Musculoskeletal Disorders 2010, 11:88
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surement of pH in morning urine to assess osteoporosis
risk [24,27], so we argue the ability to predict osteoporo-
sis in morning urine samples warranted testing. Second,
as a cohort study, the risk of confounding remains, and
there is a chance of reporting bias for the potential con-
founding variables.
Conclusion
This study indicates that two measures of acid excretion
from fasting morning urine, low urine pH and the calcu-
lated acid excretion in urine, do not identify individuals at
risk for osteoporosis, as measured using fragility fractures
and changes of bone mineral density. This study cannot
determine whether the lack of association between these
urine measures of diet acid load and bone outcomes is
due to the type of urine sample used, the lack of ability of
a single measure to reflect long-term diet acid load, or
because the acid-ash hypothesis is not predictive of bone
health. Together, this study, the recent critical review
[66], and recent meta-analyses [52-54] provide a body of
contradicting evidence for the acid-ash hypothesis. Fur-
ther research is needed to improve our understanding of
the role of diet in prevention of osteoporosis and to pro-
vide the best possible evidence to support or refute mar-
keting of novel therapies to influence health.
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